Skip to main content
. Author manuscript; available in PMC: 2016 Sep 15.
Published in final edited form as: Am J Cardiol. 2015 Jun 24;116(6):904–912. doi: 10.1016/j.amjcard.2015.06.016

Figure 2. The effect of warfarin versus aspirin on clinical outcomes for subgroups of WARCEF participants stratified by OBRI and HAS-BLED risk scores.

Figure 2

P-values represent results of tests of interaction between treatment assignment and bleeding risk subgroups identified by OBRI and HAS-BLED risk score.